Microbial therapy offers new hope for vitiligo patients
A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new...
adminph
Cartesian Therapeutics announces FDA agreement for new trial
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25 Cartesian Therapeutics has secured an agreement from the...
FDA approves new Alzheimer’s treatment regimen
Patients and care partners may find once every four weeks maintenance dosing easier The US Food and Drug Administration (FDA)...
Skin cancer: New treatment option successfully tested
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally...
Vedanta Biosciences reveals Phase 2 VE303 results
Study highlights VE303's potential in reducing recurrent CDI Vedanta Biosciences has published additional results from its Phase 2 CONSORTIUM study...
Alligator Bioscience reports survival benefit of mitazalimab with mFOLFIRINOX
Comparison shows improved survival rates for pancreatic cancer treatment Alligator Bioscience has announced positive outcomes from indirect treatment comparison studies,...
AI paves the way for personalised treatments in ageing science
A collaborative study between researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and...
Scientists design peptides to enhance drug efficacy
A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method...
Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment
Orphan drug designation offers development incentives and potential market exclusivity Zydus has announced that the USFDA has granted Orphan Drug...
Tris Pharma announces positive results from ALLEVIATE-1 trial of cebranopadol
Phase 3 trial shows promising pain relief for acute pain patients Tris Pharma, Inc. has announced positive results from its...
One of the largest global surveys of society's attitudes toward breakthrough technologies
As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm...
Innovative Health Initiative launches a trial aimed at ending Crohn’s Disease
Europe’s first biomarker trial seeks to prevent Crohn’s Disease onset In a landmark effort, the INTERCEPT project has launched Europe’s...
AstraZeneca receives positive recommendations for lung cancer treatments
NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care AstraZeneca has received two positive recommendations from the National Institute...
Study identifies benefits, risks linked to popular weight-loss drugs
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study...
AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025
Preclinical data highlights potential in treating Alzheimer's disease AlzeCure Pharma AB announced that its abstract on NeuroRestore ACD856 has been...
EC approves lazertinib in combination with amivantamab for NSCLC patients
Combination therapy shows superior survival benefit over standard treatment The European Commission (EC) has approved the marketing authorisation for LAZCLUZE...
New study paves way for immunotherapies tailored for childhood cancers
Researchers at Karolinska Institutet and the Astrid Lindgren Children's Hospital in Sweden have determined how children's immune systems react to...
UK sees 70% increase in phase I advanced therapy clinical trials in 2024
Cell and Gene Therapy Catapult reveals significant growth in UK trials The UK experienced a notable increase in advanced therapy...
Datapharm expands into US market through partnership with phactMI
Collaboration aims to enhance accessibility of medicines information Datapharm has announced its expansion into the United States through a new...
Short-course antibiotics can revolutionize healthcare
Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis. Researchers from...
